VTYX

Sitryx

This biopharmaceutical company develops oral small molecule medicines that target immune cell metabolism to treat patients with chronic autoimmune and inflammatory diseases.

ALMS

This biopharmaceutical company develops oral therapies to treat patients with immune-mediated diseases, neuroinflammatory conditions and neurodegenerative disorders.

PHVS

This company develops oral therapies to treat and prevent hereditary angioedema attacks for patients with rare diseases.

Viridiantherapeutics

This company develops antibody treatments for patients living with rare autoimmune conditions and thyroid eye disease.

Kezar Life Sciences

This clinical-stage biopharmaceutical company develops small-molecule therapeutics for patients with autoimmune diseases and inflammatory conditions.

Biopharmaceutical company

This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.

Sitryx Therapeutics

The company develops oral small molecule therapies to treat patients with autoimmune and inflammatory diseases by regulating immune cell metabolism.

Abivax

This biotechnology company develops an oral small molecule drug to treat patients suffering from chronic inflammatory diseases, including ulcerative colitis and Crohn’s disease.